SULFONIERTE HARZE MIT THERAPEUTISCHER WIRKSAMKEIT, DEREN DARSTELLUNG SOWIE DIESE ENTHALTENDE ARZNEIMITTEL
A pharmaceutical compound characterized by a delayed release of the therapeutically active component, comprising a sulfonic type ion exchange resin and cis(± )-3-ace- tytoxy-5- [2- (dimethylamino) ethyl] -2,3-dihydro-2- (4-methoxyphenyl) -1,5-benzothiazepin-4(5H)one, or cis(±)-3-hydroxy-5- [2-(dimet...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A pharmaceutical compound characterized by a delayed release of the therapeutically active component, comprising a sulfonic type ion exchange resin and cis(± )-3-ace- tytoxy-5- [2- (dimethylamino) ethyl] -2,3-dihydro-2- (4-methoxyphenyl) -1,5-benzothiazepin-4(5H)one, or cis(±)-3-hydroxy-5- [2-(dimethylamino) ethyl] -2,3-dihydro-2- (4-methoxyphenyl) -1,5-benzothiazepin-4(5H)one as a therapeutically active compound.A process for the preparation of the active compound.A pharmaceutical composition including said active compound, and use of said composition for the prophylaxis and therapy of acute and chronical coronary insufficiency and of arterial hypertension. |
---|